Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robbie Godwin

Diagnostic Radiology Columbus, MS Doctor of Osteopathy

NPI 1073721544 CMS profile 393719

2520 5Th St N, Columbus, MS 39705

Open in the dashboard

General payments

$1,830

77 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robbie Godwin of Columbus, MS is reported in the CMS Open Payments database as having received $1,830 across 77 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $166 9
2024 General $221 8
2023 General $149 6
2022 General $86 5
2021 General $765 27
2020 General $167 10
2019 General $276 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robbie Godwin
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Robbie Godwin were reported at $166. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Robbie Godwin Diagnostic Radiology median Middle half National median
2019 $276 $108 $29–$318 $163
2020 $167 $65 $21–$252 $114
2021 $765 $92 $24–$292 $132
2022 $86 $104 $29–$294 $149
2023 $149 $110 $29–$337 $160
2024 $221 $113 $30–$356 $164
2025 $166 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bard Peripheral Vascular, Inc. $463 29 payments
  2. Penumbra, Inc. $399 16 payments
  3. W. L. Gore & Associates, Inc. $376 16 payments
  4. Inari Medical, Inc. $234 5 payments
  5. Stryker Corporation $100 1 payment
  6. Boston Scientific Corporation $91 3 payments
  7. Medtronic, Inc. $85 5 payments
  8. Argon Medical Devices, Inc. $59 1 payment
  9. Medtronic USA, Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,830 77 payments
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $467 10 payments
  2. Penumbra System $219 10 payments
  3. Indigo System $179 6 payments
  4. VIABAHN Endoprosthesis with PROPATEN Bioactive Surface $144 4 payments
  5. LUTONIX BD Interventional - Peripheral Intervention $143 9 payments
  6. VIABAHN VBX Balloon Expandable Endoprosthesis $129 5 payments
  7. SPINEJACK $100 1 payment
  8. LUTONIX BD Interventional Peripheral Intervention $66 4 payments
  9. Clot Management $59 1 payment
  10. DIREXION $55 1 payment
  11. Other $377 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 178 billing codes

Paid by Medicare

$106,256

Medicare's payments for the services billed

Medicare patients

680

Average age 72

Services billed

1,363

345 women, 335 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Diabetes 48%
Chronic kidney disease 47%
Ischemic heart disease 41%
Heart failure 37%
COPD 31%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

77 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record